why choose us

First received: September 23, 2022

Clinical Trial: Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer

Study Status: Completed

Recruit Status: RECRUITING

Condition: Benign Breast Neoplasm

Study Type: INTERVENTIONAL


Official Title: Targeted Prevention of Postpartum-Related Breast Cancer

Brief Summary: This phase II trial tests whether low-dose aspirin can affect markers of inflammation in postpartum (after childbirth) patients with benign breast disease planning to have a breast biopsy.Chronic inflammation may increase the risk of postpartum related breast cancer.Low-dose aspirin is a non-steroidal anti-inflammatory drug.Giving low-dose aspirin may affect markers of inflammation in blood and tissue and may prevent postpartum related breast cancer.

Read more